Condensed Balance Sheets - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 15,900,297	$ 5,761,568
Accounts receivable	10,000,000
Prepaid expenses and other current assets	10,507,161	679,461
Total current assets	36,407,458	6,441,029
Property and equipment, net	120,769	130,081
Other assets:
Goodwill	7,647,267	7,647,267
Other non-current assets	335,404	395,311
Total assets	44,510,898	14,613,688
Current liabilities:
Accounts payable	428,925	1,672,109
Accrued expenses	2,226,425	3,781,101
Deferred collaboration funding	20,715,764
Other current liabilities	10,664,321	692,336
Total current liabilities	34,035,435	6,145,546
Other non-current liabilities	65,818	243,808
Total liabilities	34,101,253	6,389,354
Commitments and Contingencies (Note 6)
Stockholders’ equity:
Preferred stock, $0.0001 par value; authorized 10,000,000 shares; none issued and outstanding
Common stock, $0.0001 par value; authorized 150,000,000 shares; 14,310,244 and 13,233,137 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively	1,431	1,324
Additional paid-in capital	111,057,347	107,358,971
Accumulated deficit	(100,649,133)	(99,135,961)
Total stockholders’ equity	10,409,645	8,224,334
Total liabilities and stockholders’ equity	$ 44,510,898	$ 14,613,688